Cargando…

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy

SIMPLE SUMMARY: Endogenous viruses are “ancient” viruses that have coevolved with their host species for millions of years, developing strategies to maintain an equilibrium state with their host. In particular, human endogenous retroviruses (HERVs) are permanently integrated and make up over 8% of o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrizzo, Annacarmen, Ragone, Concetta, Cavalluzzo, Beatrice, Mauriello, Angela, Manolio, Carmen, Tagliamonte, Maria, Buonaguro, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122352/ https://www.ncbi.nlm.nih.gov/pubmed/33919186 http://dx.doi.org/10.3390/cancers13091999

Ejemplares similares

Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
por: Ragone, Concetta, et al.
Publicado: (2022)

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
por: Mauriello, Angela, et al.
Publicado: (2019)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
por: Mauriello, Angela, et al.
Publicado: (2021)

Novel Molecular Targets for Hepatocellular Carcinoma
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Molecular mimicry and cancer vaccine development
por: Tagliamonte, Maria, et al.
Publicado: (2023)

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
por: Ragone, Concetta, et al.
Publicado: (2021)

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
por: Manolio, Carmen, et al.
Publicado: (2022)

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response
por: Tagliamonte, Maria, et al.
Publicado: (2021)

Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy
por: Mauriello, Angela, et al.
Publicado: (2020)

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach
por: Petrizzo, Annacarmen, et al.
Publicado: (2014)

Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015)

Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
por: Petrizzo, Annacarmen, et al.
Publicado: (2018)

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
por: Petrizzo, Annacarmen, et al.
Publicado: (2017)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
por: Petrizzo, A., et al.
Publicado: (2018)

Innate immunity and hepatitis C virus infection: a microarray’s view
por: Buonaguro, Luigi, et al.
Publicado: (2012)

Pattern of activation of human antigen presenting cells by genotype GII.4 norovirus virus-like particles
por: Ponterio, Eleonora, et al.
Publicado: (2013)

Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy
por: Buonaguro, Luigi, et al.
Publicado: (2008)

A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice
por: Tagliamonte, Maria, et al.
Publicado: (2016)

Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Implication of Human Endogenous Retrovirus Envelope Proteins in Placental Functions
por: Lokossou, Adjimon Gatien, et al.
Publicado: (2014)

Human endogenous retroviruses in cancer: Oncogenesis mechanisms and clinical implications
por: Kitsou, Konstantina, et al.
Publicado: (2022)

Reactivated endogenous retroviruses promote protein aggregate spreading
por: Liu, Shu, et al.
Publicado: (2023)

Endogenous Retroviruses and Human Evolution
por: Khodosevich, Konstantin, et al.
Publicado: (2002)

Immunity to human endogenous retroviruses
por: Nixon, Douglas F
Publicado: (2011)

Paleovirology of human endogenous retroviruses
por: Gifford, Robert J, et al.
Publicado: (2009)

Human endogenous retroviruses and cancer
por: Gonzalez-Cao, María, et al.
Publicado: (2016)

Human-Specific Endogenous Retroviruses
por: Buzdin, Anton
Publicado: (2007)

Human endogenous retroviruses and ageing
por: Hurme, Mikko, et al.
Publicado: (2021)

The Role of Human Endogenous Retroviruses in Cancer Immunotherapy of the Post-COVID-19 World
por: Logotheti, Stella, et al.
Publicado: (2023)

Antibodies against endogenous retroviruses promote lung cancer immunotherapy
por: Ng, Kevin W., et al.
Publicado: (2023)

Reconstitution of an Infectious Human Endogenous Retrovirus
por: Lee, Young Nam, et al.
Publicado: (2007)

Endogenous retroviruses in the human genome sequence
por: Griffiths, David J
Publicado: (2001)

Human Endogenous Retroviruses in Neurological Diseases
por: Küry, Patrick, et al.
Publicado: (2018)

Human Endogenous Retroviruses in Glioblastoma Multiforme
por: Yuan, Zihao, et al.
Publicado: (2021)

Human endogenous retroviruses in development and disease
por: Mao, Jian, et al.
Publicado: (2021)

The discovery of endogenous retroviruses
por: Weiss, Robin A
Publicado: (2006)

Endogenous retroviruses in primates
por: Brown, Katherine, et al.
Publicado: (2011)

Multiparametric Analyses of Human PBMCs Loaded Ex Vivo with a Candidate Idiotype Vaccine for HCV-Related Lymphoproliferative Disorders
por: Petrizzo, Annacarmen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v1radhdv5bv4jd9uumsf0p828d